INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 95 filers reported holding INSTIL BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $609,000 | -5.4% | 125,869 | -9.7% | 0.02% | +5.3% |
| Q2 2022 | $644,000 | -13.6% | 139,354 | +101.2% | 0.02% | 0.0% |
| Q1 2022 | $745,000 | -24.6% | 69,264 | +20.0% | 0.02% | -26.9% |
| Q4 2021 | $988,000 | -36.5% | 57,719 | -33.7% | 0.03% | -44.7% |
| Q3 2021 | $1,556,000 | -13.6% | 87,014 | -6.7% | 0.05% | -14.5% |
| Q2 2021 | $1,801,000 | – | 93,230 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 8,478,790 | $151,558,000 | 16.71% |
| VR Adviser, LLC | 6,865,076 | $122,713,000 | 15.76% |
| Vivo Capital, LLC | 12,486,787 | $223,201,000 | 10.02% |
| Samsara BioCapital, LLC | 2,145,395 | $38,349,000 | 6.02% |
| Fairmount Funds Management LLC | 673,905 | $12,046,000 | 4.38% |
| Logos Global Management LP | 1,277,091 | $22,828,000 | 1.65% |
| RA Capital Management | 4,870,793 | $87,065,000 | 1.21% |
| Nicholas Investment Partners, LP | 679,171 | $12,140,000 | 0.89% |
| HighVista Strategies LLC | 72,079 | $1,288,000 | 0.85% |
| Parametrica Management Ltd | 46,225 | $826,000 | 0.62% |